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Abstract
Background: The bacterial pathogen Streptococcus pneumoniae colonizes the nasopharynx prior to causing disease,
necessitating successful competition with the resident microflora. Cytokines of the IL-17 family are important in host defence
against this pathogen but their effect on the nasopharyngeal microbiome is unknown. Here we analyse the influence of
IL-17 on the composition and interactions of the nasopharyngeal microbiome before and after pneumococcal colonization.
Results: Using a murine model and 16S rRNA profiling, we found that a lack of IL-17 signalling led to profound
alterations in the nasal but not lung microbiome characterized by decreased diversity and richness, increases in
Proteobacteria and reduction in Bacteroidetes, Actinobacteria and Acidobacteria. Following experimental
pneumococcal nasal inoculation, animals lacking IL-17 family signalling showed increased pneumococcal colonization,
though both wild type and knockout animals showed as significant disruption of nasal microbiome composition, with
increases in the proportion of Proteobacteria, even in animals that did not have persistent colonization. Sparse
correlation analysis of the composition of the microbiome at various time points after infection showed strong positive
interactions within the Firmicutes and Proteobacteria, but strong antagonism between members of these two phyla.
Conclusions: These results show the powerful influence of IL-17 signalling on the composition of the nasal
microbiome before and after pneumococcal colonization, and apparent lack of interspecific competition between
pneumococci and other Firmicutes. IL-17 driven changes in nasal microbiome composition may thus be an important
factor in successful resistance to pneumococcal colonization and potentially could be manipulated to augment host
defence against this pathogen.
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Background
The microbial environment of the nasopharynx is diverse
and medically important, as this is the usual niche of a
number of important human pathogens such as Neisseria
meningitidis, Haemophilus influenzae type B, and Strepto-
coccus pneumoniae [1–4]. Nasal colonisation with such
organisms precedes the development of disease and so
understanding the dynamics of nasal colonisation and
developing tools to control or limit nasal colonisation are
important research goals. Host factors that affect
colonization may alter immune defences against a
pathogen but may also alter the composition of the resi-
dent microbiome [5, 6]. To be able to colonize initially, a
pathogen not only requires the ability to overcome host
defences but also to be able to compete effectively with
the resident microbiota. Hence, it is important to under-
stand the effects of host immune responses not only on
the pathogen directly but also on the richness and
diversity of the microbiome at the site of colonization,
since this will influence the resistance and resilience to
pathogen invasion [7].* Correspondence: tom.evans@glasgow.ac.uk1Institute of Infection, Immunity and Inflammation, University of Glasgow,
Glasgow, UK
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The human pathogen S. pneumoniae (the pneumococ-
cus) is an important worldwide cause of pneumonia, men-
ingitis, sepsis, middle ear infections, and other invasive
diseases, responsible for over 1 million deaths annually
[8]. Colonization of the nasopharynx by this microbe is
transient, usually less than 6 months, and will induce a
specific antibody response directed at the carbohydrate
capsule of the bacterium that is thought to contribute to
clearance [2, 9]. Spread of the pathogen from the site of
colonization in the nasopharynx to the lower airways is
thought to proceed by micro-aspiration [10, 11]. In this
site as well, the resident microbiome will also influence
the ability of the pneumococcus to cause disease, and as
with the nasopharynx, the composition of the lung micro-
biome will also potentially be altered by specific immune
mechanisms.
Host and pathogen factors are important in pneumo-
coccal colonization. Specific opsonophagocytic antibodies
to the bacterial carbohydrate capsule are very effective at
reducing colonization and induction of such antibodies by
vaccination has been highly successful in reducing
colonization by specific pneumococcal capsular serotypes
[12]. However, cell-mediated immunity appears to be
more important in naturally acquired immunity to
pneumococcal colonization. In particular, CD4+ cells pro-
ducing cytokines of the interleukin-17 (IL-17) family,
Th17 cells, have been shown to be critical for primary
clearance of colonizing pneumococci and subsequent sec-
ondary immune protection [13–15]. Several putative
pneumococcal vaccines have been dependent on IL-17
mediated immunity for efficacy in mouse models [13, 16–
18]. Although the immune mechanisms by which IL-17
provides defence against pneumococcal colonization have
been well described, no studies have been made of the ef-
fects of this cytokine on the nasopharyngeal and lung
microbiome before and after pneumococcal colonization.
Changes in these bacterial populations will also influence
whether an invading pneumococcal strain can compete
with the resident microflora and become an established
colonizer, and how rapidly it will be cleared. Competition
between the invading pneumococcus, other competing
pneumococcal strains and resident bacteria is also influ-
enced by pathogen factors. Between-strain competition
has been demonstrated in both animal models and human
colonization [19–21]. For example, studies analysing the
prevalence of double colonization with two different
strains of pneumococci show that colonization with one
strain is very inhibitory to acquisition of a second strain
[21]. Bacteriocins produced by pneumococci have been
shown to be important in mediating intraspecies competi-
tion in animal models [19]. Pneumococcal bacteriocins
can also kill related bacterial species such as Micrococcus
and Lactococcus species [22]; the biological importance of
such activity in establishing colonization is not clear.
We hypothesised that IL-17 would be important in deter-
mining the composition of the normal nasopharyngeal and
lung microbiome, and that following pneumococcal
colonization, IL-17 would drive changes in nasopharyngeal
microbiome composition. Additionally, we postulated that
colonization by a pneumococcal strain would result in a
reduced frequency of closely related bacteria within the
Firmicutes phylum. Here, we use a murine model of
experimental pneumococcal nasopharyngeal colonization
to explore the influence of IL-17 on acquisition and car-
riage of this microbe, using mice with a targeted deletion of
the common IL-17 receptor gene, Il17ra. Using 16S riboso-
mal DNA sequencing, we show that lack of IL-17 signalling
produces profound effects on the nasopharyngeal but not
the lung microbiome, with a loss in richness and diversity,
expansion of Proteobacteria, and decreased abundance of
Bacteroidetes and Acidobacteria. Following experimental
inoculation of S. pneumoniae, in both wild type and Il17ra
knockout (KO) animals there were multiple changes in the
composition of the nasal microbiome, even in animals that
did not show established colonization. In the lung, only the
Il17ra KO animals showed changes in microbiome com-
position, with invasion of the inoculated pneumococcus
but without evidence of clinical disease. Rather than
inhibiting related Firmicutes, pneumococcal colonization
promoted their presence while antagonising Proteobacteria.
Given the risk of invasive disease resulting from
colonization, these results reveal important host and
pathogen determined changes in the nasal microbiome that
could be exploited to limit pneumococcal disease.
Results
Experimental Set Up
To determine the contributions of IL-17 signalling to the
composition and behaviour of the nasopharyngeal and lung
microbiome before and after pneumococcal colonization,
we utilized IL-17RA knockout mice and wild type mice,
both bred in house and cohoused for 6 weeks after weaning
as described in the Methods. Groups of mice were left un-
treated or inoculated with the SRL1 strain of pneumococ-
cus in the anterior nares and the composition of recovered
bacteria before and at various times after inoculation was
analysed by 16S rDNA sequencing. Only 1 out of 96 total
samples failed to amplify the 16S V1-V2 region but other
samples were successfully amplified and sequenced with a
median of 6.7 x 104 (range 2.1-13.3) reads per sample.
These were clustered into 2632 operational taxonomic
units (OTUs). Rarefaction curves of the sample showed
excellent depth, with all samples approaching an asymptote
(Additional file 1: Figure S1A). Numerical estimate of
sample coverage using the abundance-based coverage esti-
mator [23] showed a median OTU coverage of 92.7%, with
no significant difference between wild type and IL-17RA
knockout animals (Additional file 1: Figure S1B).
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To confirm that a lack of the IL-17RA receptor resulted in
expected changes in IL-17 cytokine targets, we assayed for
known IL-17 targets following SRL1 infection in wild type
and IL-17RA knockout mice (Additional file 1: Figure S2).
We confirmed that the known IL-17 target genes beta-
defensin 4, S100A8, and macrophage inhibitory protein-1
alpha [24] were strongly induced following SRL1 infection in
wild type animals, but their expression was significantly and
strongly abrogated in IL-17RA knockout mice.
Resting nasal microbiome
The wild type nasal microbiome had a median of 292 OTUs
observed per sample. The microbiome was principally
composed of Proteobacteria (35.7%) and Firmicutes (30.0%)
with smaller populations of Bacteroidetes (13.2%) and Acti-
nobacteria (10.6%). A number of recognised mouse patho-
gens were present including Streptococcus, Staphylococcus
and Pasteurella sp., and these were present in all mice stud-
ied. α-diversity among Il17ra KO mice was significantly
lower compared to wild type as measured using the inverse
Simpson diversity index (Fig. 1a). OTU count (richness) was
also significantly lower in Il17ra KO mice (Fig. 1b). OTU
abundance curves of the wild type and IL-17RA KO animals
show the clear differences in richness and evenness between
the two groups (Fig. 1c). Ordination using two-dimensional
non-metric multidimensional scaling analysis (NMDS)
based on the Bray-Curtis dissimilarity index between each
animal sample, showed clear separation of the two groups
that was highly statistically significant (Fig. 1d), using
permutational multivariate analysis of variance (PERMA-
NOVA) [25] .
Distribution of bacterial phyla and individual OTUs
between the wild type and IL-17RA knockout animals is
summarized in Fig. 2. Individual OTUs within phyla are
Fig. 1. Analysis of resting microbiome of wild type and Il17ra KO mice. a Inverse Simpson Diversity Index and (b) number of observed OTUs
between wild type and Il17ra KO mice (IL-17-/-). Each symbol is the result from an individual animal. Horizontal line denotes median. Significant
differences between the groups are shown: ***, p < 0.001, * p < 0.05, Mann-Whitney test. c Rank abundance curves for the observed OTUs of WT
(black) and Il17Ra knockout mice (red). d Non-metric multidimensional analysis with ellipses representing 80% confidence limit for each group.
Differences between the groups were significant (***. P < 0.0001, using PERMANOVA)
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Fig. 2. (See legend on next page.)
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shown in Fig. 2a. Compared to wild type, Il17ra KO mice
had increased abundance of Proteobacteria and decreased
abundance of Bacteroidetes, Actinobacteria, and Acidobac-
teria (Fig. 2b). Notably, however, there was not a difference
in the relative abundance of Firmicutes, the phylum con-
taining Streptococci, between the two groups of animals.
The decreased diversity of Il17ra KO mice was reflected in
small numbers of OTUs dominating the nasal microbiome
of these animals. The three most abundant OTUs (OTT 4:
Pasteurella, OTU 11: Streptococcus and OTU 23: Escheri-
chia/Shigella) had a combined abundance of 49.4% whereas
the 17 most abundant OTUs would be required to reach
the same combined abundance in wild type mice. OTU23
was not one of the 20 most abundant OTUs in the wild
type mice but as shown in Fig. 2a, was a significant compo-
nent of the nasal microbiome in the IL17RA knockout
animals.
Resting Lung Microbiome
There was a marked difference between nasal and the
lung microbiome, as shown in Fig. 3. Both richness and
diversity was significantly less in the lungs than in in the
nasal microbiome (Fig. 3a and b). NMDS analysis
showed the microbiome composition between the two
sites is considerably different (Fig. 3c). In particular, Pro-
teobacteria (the most abundant phylum in the lung
microbiome) were considerably more abundant in the
lung compared to the nasal site. Fibrobacteres were also
significantly more abundant; Firmicutes, Bacteroidetes
and Actinobacteria were all significantly less abundant in
the lung compared to the nasal site (Fig. 3d).
Next, we compared the composition of the lung
microbiome in wild type mice compared to the IL-17RA
knockout animals (Fig. 3e). In contrast to the nasal sam-
ples, there was considerable overlap in the composition
of the samples from the two groups, although the differ-
ences observed were significant. At phylum and family
level, no significant differences between the two groups
of animals were found (shown for phyla in Fig. 3f ).
Nasal colonisation with S. pneumoniae
Mice were inoculated with the SRL1 strain of pneumococ-
cus and the nasal and lung microbiome analysed by 16S
ribosomal DNA analysis at days 3, 7 and 14. Conventional
culture analysis of nasal wash of mice colonised with S.
pneumoniae are shown in Fig. 4a. No mice had any
colonies of S. pneumoniae on nasal wash prior to experi-
mental exposure. Inoculation with 5 x 105 cfu/mouse in-
duced low level colonisation in both wild type and Il17ra
KO mice which peaked at 3 days following inoculation, and
then fell over the 14 days of the experiment. Il17ra KO
mice had significantly higher colonisation density in the
nose than wild type animals (P < 0.001, 2-way ANOVA).
Similarly, lung colonization by SRL1 peaked at 3 days after
inoculation and fell thereafter (Fig. 4b). The difference
between wild type and IL-17RA knockout mice was signifi-
cant (p < 0.003, 2-way ANOVA). In a separate experiment,
we monitored the neutrophils within the nasal wash before
and after introduction of pneumococci. Prior to inocula-
tion, both groups of animals showed a low percentage of
recovered neutrophils (Additional file 1: Figure S3). 7 days
following introduction of pneumococci, the percentage of
neutrophils increased in both sets of animals, but neutro-
phils in the nasal wash were significantly lower in the Il17ra
KO animals compared to the wild type controls (Additional
file 1: Figure S3).
Nasal and Lung microbiome following colonisation
OTU count (richness) following nasal colonisation is shown
in Fig. 4c for the nasal microbiome and Fig. 4d for the lung
microbiome. In the nasal microbiome, wild type animals
showed a drop in OTU count following pneumococcal in-
oculation that partially recovered by day 14. Conversely, the
IL-17RA knockout animals showed a lower initial OTU
count that dropped to a small degree following pneumo-
coccal inoculation (Difference between the groups signifi-
cant, p< 0.001, 2-way ANOVA). In the lung, there was a
slight reduction in diversity following inoculation; there was
no significant difference between the wild type and IL-
17RA knockout animals (Fig. 4d). Wild type animals expe-
rienced a fall in inverse Simpson diversity index (Fig. 4e))
following nasal colonisation which appeared to be reversing
by day 14. In contrast, there was little difference in inverse
Simpson diversity index among Il17ra KO mice through-
out, a significant difference between the groups (p < 0.001,
2-way ANOVA). In the lung, there was little change in
diversity through the experiment and no significant
difference between the animal groups (Fig. 4f).
OTU2 was identified as having an identical sequence to
the SRL1 pneumococcal strain. Low (< 1%) levels of OTU2
were found in nasal wash samples from mice that had not
been inoculated with SRL1. Pneumococcus is not a normal
(See figure on previous page.)
Fig. 2. Analysis of resting wild type and Il17ra KO microbiome. a The 20 most abundant OTUs from the resting dataset are plotted individually with the
remainder combined. Data are pooled from several mice (n = 8-9/group) and blocks of similar colours represent common bacterial phyla. Significance
testing using Kruksal-Wallis test corrected for multiple comparisons is shown in the legend. q value represents outcome of testing for difference in
abundance of major phyla between wild type and Il17ra KO mice. b Plots showing log normalised relative abundance of the 6 most abundant bacterial
phyla. Points are individual animals. Box encloses the interquartile range, line is the median and the whiskers extend to 1.5 x above and below the
interquartile range
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pathogen of mice, and no colonies of pneumococcus were
ever recovered from nasal wash of these animals. Moreover,
using amplification of the capsular polysaccharide gene
cpsA, a highly specific marker for S. pneumoniae, we never
found any signal in nasal washes from unexposed mice, but
consistently found that samples from inoculated mice were
positive by this assay (Additional file 1: Figure S4). The
closest ribosomal sequence to OTU2 in our data set were
from species of viridans streptococci which we conclude
are responsible for the low-level signal from OTU2 seen in
control uninoculated animals. Thus, we conclude that the
OTU2 signal in control uninoculated mice is from viridans
group streptococci and that the marked expansion of
OTU2 following SRL1 inoculation indicates the presence of
this added organism.
The abundance of OTU2 following inoculation with
SRL1 is shown in Fig. 4g and h in nose and lung respect-
ively. The abundance in both sites increased markedly
following inoculation, peaking at 7 days after inocula-
tion. In both sites, levels of this OTU were significantly
higher in the IL-17RA knockout animals compared to
wild type (2-way ANOVA, p < 0.05 for both sites).
Changes in the relative abundance of the top 20 most
abundant OTUs within the nose following pneumococcal
colonization are shown in Fig. 5a. This shows the hetero-
geneity of responses in individual animals. However, some
clear patterns are evident. Most wild type mice had low
abundance (<10%) of OTU 2 and no mouse exceeding
25%. In contrast, several Il17ra KO mice had high abun-
dances of OTU 2 exceeding 50%; these results are summa-
rized in Fig. 4g. Even in animals that did not have high
levels of OTU2 colonization, there were marked changes
in their microbiome composition. For both wild type and
Il17ra KO mice, there was a significant difference in the
microbiome composition following pneumococcal inocu-
lation, shown using non-metric multidimensional scaling
(Fig. 5b). In both wild type and in Il17RA knockout ani-
mals, there is an expansion in proteobacteria in animals
that do not show significant colonization with OTU2
(Additional file 1: Figure S5A). This was also true in the
IL-17RA knockout animals (Additional file 1: Figure S5A),
showing that this response is not driven by IL-17.
Changes in the relative abundance of the top 20 most
abundant OTUs within the lungs following pneumococcal
colonization are shown in Fig. 6. In wild type animals, there
was no significant difference in microbiome composition
following pneumococcal inoculation (Fig. 6a and b).
However, there was a significant shift in the composition of
the lung microbiome of the Il17ra KO mice following the
introduction of pneumococci (Fig. 6a and b). Wild type
animals showed little evidence of OTU2 introduction into
the lung microbiome. However, in the Il17ra KO mice,
some of the colonized animals showed a marked preponder-
ance of OTU2, particularly at day 7 after inoculation (as
summarized in Fig. 4h). These levels correlated with the
presence of OTU2 in the nose of the same animal at the
same time. Despite this preponderance of OTU2 within the
lung microbiome, these animals remained completely well
with no signs of any disease.
Sparse Correlation Analysis of Nasal Microbiome Before
and After Pneumococcal Colonization
In order better to understand the multiple interactions be-
tween the different bacterial populations within the naso-
pharynx, we performed a sparse correlation analysis of the
different bacterial OTUs before and after colonization,
using the SparCC network inference tool that corrects for
the compositional nature of microbiome data (Fig. 7). This
approach is important since conventional correlations be-
tween organisms in compositional microbiome analysis is
prone to error, since expansion of one OTU will perforce
reduce the percentage of the other OTUs even if there is
no direct interaction with these other microbes.
In both wild type and IL-17RA knockout animals, there
is little evidence of any significant correlation between
OTUs in resting animals (Fig. 7). Following SRL1 inocula-
tion, there was a noticeable change in the observed sparse
correlations between different OTUs. In wild type animals,
there is an increase in the proportion of Proteobacteria
which show a marked positive correlation between the ma-
jority of OTUs within this phylum. This is most evident at
7 days after SRL1 inoculation and is returning to baseline
at 14 days. Similarly, there is a positive correlation between
most OTUs of the Firmicutes, again most evident at day 7.
Correspondingly, there was a notable negative correlation
between OTUs within the Firmicutes and those of the
Proteobacteria, most marked at day 7 and returning to
baseline at day 14. In the IL-17RA knockout animals, there
was a similar pattern of positive correlations within the
Proteobacteria noticeable at 3 and 7 days and even more
marked at day 14. Positive correlations within the Firmi-
cutes were also evident, again with different kinetics to the
wild type animals, and still very evident at 14 days after
SRL1 inoculation.
(See figure on previous page.)
Fig. 3. Analysis of lung microbiome. a OTU count and (b) Inverse Simpson index in samples rarefied to even sequencing depth. c
Multidimensional scaling analysis of samples as indicated with ellipses indicating 80% confidence of sample distribution. d Plots showing log
normalised relative abundance of the 6 most abundant bacterial phyla. e Multidimensional scaling analysis of lung microbiomes from groups as
indicated, with ellipses indicating 80% confidence of sample distribution. f Composition of lung microbiome grouped by phylum for individual
animals. All symbols, statistical tests and significance levels as in Fig. 1
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We explored the positive correlations observed within
the Firmicutes in more depth (Fig. 8), for wild type ani-
mals at day 7 (Fig. 8a) and for the IL-17RA knockout
animals at day 14 (Fig. 8b); these were the times showing
the maximal positive correlations within the phylum.
The marked positive correlations between most of the
Fig. 4. Comparison of nose and lung microbiome following Pneumococcal Inoculation. a Nasal and (b) lung colonisation with Streptococcus
pneumoniae assessed by routine culture methods. Differences between the groups were significant, 2-way ANOVA, (a, p=0.0003, b, p=0.003). Nose
(c, e and g) and lung (d, f and i) microbiomes compared for OTU count (c and d), Diversity (e and f) and OTU2 abundance (g and h). Symbols
for box and whisker plots as in Fig. 1. P values are for 2-way ANOVA between the wild type and Il17ra KO animal groups. ns = not significant
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different members of the Firmicutes are seen for both
groups of animals. The figures within the boxes show
the p values of the correlations as described in the
Methods. Although few of these reach significance, (p <
0.05), only 1 OTU (OTU65) shows any sign of a negative
correlation (< -0.5), the majority of other interactions
between the members of the Firmicutes in both WT and
IL-17RA knockout animals at the time points shown are
positive (correlation > 0.5). This is a highly significant
difference from a calculated expected value based on an
even distribution of correlation values (p < 0.0001, Chi-
squared on proportions for both WT at day 7 and IL-
17KO at day 14). Thus, the presence of OTU2 generally
acts to promote the presence of other bacterial OTUs
within the Firmicutes. We also found a significant posi-
tive correlation between the density of SRL1
colonization and the relative proportions of other
Firmicutes (Additional file 1: Figure S5B). Thus, these
results suggest our hypothesis that colonization with S.
pneumoniae would reduce the abundance of related
Firmicutes through inter-specific competition through
agents such as bacteriocins is not true. The significance
of this is considered further in the Discussion.
In both the lung and the nose microbiome, we noted that
after inoculation with SRL1, some animals showed an in-
crease in the proportion of OTU1, an Ochrobactrum spe-
cies. These were animals that in general had very low levels
of OTU2. We tested this negative correlation between
OTU1 and OTU2 by fitting a generalized linear model to
the rarefied abundance data of OTU1 and OTU2 (Fig. 9).
In the upper respiratory tract of un-exposed animals, there
was a strong positive correlation between OTU1 and
OTU2 (P < 0.0001) whereas among exposed animals the
correlation was strongly negative (P < 0.0001). A similar
pattern was repeated in the lower respiratory tract samples
among exposed mice (P < 0.0001), although in this case
there was no correlation among unexposed mice (P=0.25).
Differences in Gene Function between Wild Type and
IL-17RA KO Nasal Microbiomes
Finally, we compared the gene function of the nasal
microbiome between wild type and IL-17RA knockout
animals using Tax4Fun as described in the Methods to
infer gene composition from the 16S amplicon analysis.
KEGG Orthology Classifications between the two groups
of animals are shown in Table 1. There were significant
increases in the IL-17RA knockout animals in mapped
genes belonging to the Glycan biosynthesis and metabol-
ism and Infectious Diseases: Bacterial categories, with
significant reductions in three other categories as shown.
The Infectious Diseases: Bacterial category includes
genes known to be important in E. coli infection. To-
gether with the data showing the increased abundance
of Proteobacteria in the nasal microbiome of the IL-
17RA knockout mice (Fig. 2b) suggests IL-17 actions
normally act to resist the presence of microbes such as
E. coli in the nasal microbiome.
Discussion
Much more is known of the gastrointestinal microbiome
compared to that of the nose. Studies have shown that
the microbiome at this site resembles the skin micro-
biome [1] and is distinct from the lung microbiome,
which would appear to be derived from the oral bacterial
communities [26, 27]. Immediately following birth, the
nasopharyngeal microbiome in humans is composed of a
mixed community derived from many different niches
[28]. Soon thereafter, however, the composition of this
site differentiates into a more stable skin-like commu-
nity. Mode of delivery has some limited impact on the
dynamics of this process [28]. In our study, the resting
nasopharyngeal microbiome was very similar between
co-caged individuals of the same genotype but with sig-
nificant differences between wild type and Il17ra KO
mice. In contrast, human twin studies suggest that host
genetics play little role in the composition of the nasal
microbiota [29]. However, such studies cannot give in-
formation as to the effect of defined genetic differences
in key immune response pathways as studied here. In-
deed, another study investigating the role of type III
interferon in susceptibility to Staphylococcus aureus
superinfection found a significant impact of deletion of
the gene encoding the type III interferon receptor on the
composition and dynamics of the murine nasal micro-
biome following influenza infection [5]. In contrast to
the differences observed in the nasal microbiome be-
tween wild type and Il17ra KO animals, we found very
similar bacterial communities in the lungs of these
animals.
Our experiments utilised animals with a genetic defect
in IL-17RA, the common receptor subunit for IL-17
family cytokines. Previous work has shown such animals
(See figure on previous page.)
Fig. 5. OTU level analysis of individual nasal microbiomes of wild type and Il17ra KO mice with and without artificial inoculation with S. pneumoniae. a
The 20 most abundant OTUs from the dataset are plotted individually with the remainder combined. Data are grouped as unchallenged (0) or days
following inoculation. Blocks of similar colours represent common bacterial phyla. OTU 2 is the cluster containing the expected sequence of the strain
(SRL1) used in these experiments and is outlined in red. b 2 dimensional NMDS plots of the nasal microbiome before and after pneumococcal
inoculation. Each animal is plotted as a number corresponding to the time (days) when the sample was taken after pneumococcal inoculation.
P values are for PERMANOVA testing of differences between animals before and after pneumococcal introduction
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Fig. 6. OTU level analysis of individual lung microbiomes of wild type and Il17ra KO mice with and without artificial inoculation with S.
pneumoniae. a Data plotting as in Fig. 5a but for the lung microbiome. b as Fig. 5b but for the lung microbiome
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are defective in pathogen-induced IL-17 signalling [30]
and other studies have shown the lack of IL-17 RA abol-
ishes response to IL-17A [31]. We also demonstrate here
that following SRL1 infection, known IL-17 cytokine
targets are not upregulated in IL-17RA knockout ani-
mals compared to wild type controls (Additional file 1:
Figure S2). Taken together, we thus feel that the changes
in microbiome we observe in IL-17RA knockout mice
directly reflect lack of IL-17 cytokine signalling.
Our study shows that lack of IL-17 signalling alters the
resting nasal microbiome, leading to increased proportion of
Proteobacteria, with reductions in Bacteroidetes, Actinobac-
teria and Acidobacteria, with a reduction in overall micro-
biome diversity and evenness. This suggests that IL-17
effectors such as neutrophils and antimicrobial peptides [32]
have a significant role in maintaining the normal micro-
biome composition, in particular reducing colonization with
potentially pathogenic Proteobacteria, such as Pasturella and
Fig. 7. Sparse correlation analysis of nasal microbiome before and after pneumococcal colonization. OTUs with more than 500 reads from the
normalised data were analysed by SparCC at time 0 and at the indicated times after pneumococcal inoculation. Each panel shows SparCC
correlation coefficients between each OTU colour coded as indicated between -1 and 1. OTUs are grouped by phylum as shown
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Escherichia species. The differences observed in the Il17ra
KO animals suggest also that there may be a low level of in-
flammation at this site in response to exposure to environ-
mental bacteria or particulate matter, which is in part
mediated by IL-17. The resting lung microbiome was distinct
from the nasal microbiome and did not differ appreciably be-
tween wild type and Il17ra KO animals. This may reflect the
lack of inflammation in resting animals, where the lung is
protected from environmental insult by the mucociliary ac-
tion of the respiratory mucosa.
Following inoculation of the nasopharynx with pneumo-
cocci, there were marked changes in both the nasal and
lung microbiome both within and between the wild type
and Il17ra KO animals. This was noticeable not only in
those animals that showed ongoing presence of the
pneumococcus within the nose but also in those animals
that had cleared the bacterium. Notably, there was an ex-
pansion of Proteobacteria at the expense of the Firmicutes
in mice that had cleared the nasal pneumococcal inocu-
lum, both in wild type and Il17ra KO animals. This may
reflect the inflammatory response induced by the intro-
duction of pneumococci, as has been noted in many stud-
ies of the effect of inflammation in the composition of the
gut microbiome [33, 34]. A dominant mechanism would
appear to be the induction of inducible nitric oxide
synthase in the mucosa, leading to increased nitrite and
nitrate in the luminal fluid. In the gut, these anions can be
used as terminal electron acceptors for the respiratory
chain in many Proteobacteria, allowing them to proliferate
at the expense of obligate anaerobic Firmicutes which
cannot use these nitrogen containing anions as electron
acceptors [35, 36]. Although it might seem that the
aerated nasal passages would be a predominantly aerobic
environment, in our study we recovered significant
proportions of strictly anaerobic Bacteroidetes in the rest-
ing nasal microbiome, as has been noted on other studies
[26, 27]. The niche for such anaerobes may be within nasal
mucus, nasal glands or at the base of nasal hairs. Thus, we
propose that the bloom in Proteobacteria after pneumo-
coccal inoculation reflects an inflammation-driven
anaerobic nitrate rich environment that favours these or-
ganisms over the Firmicutes that are limited to fermenta-
tion to derive their energy. The notable expansion of the
OTU1 identified as an Ochrobactrum species that shows a
strong negative correlation with the introduced SRL1
pneumococcal strain may also be because of this environ-
mental change. Ochrobactrum species have been shown to
have a very high ability to utilize nitrate, nitrite and other
nitrogen containing compounds as electron acceptors
[37]. A previous study of pneumococcal colonization
found a drop in diversity after pneumococcal inoculation
but not the other differences outlined above, probably
because it utilised a 10 x greater inoculating dose of
pneumococci [38].
How then does the pneumococcus establish itself in the
nasal bacterial community and outcompete the other con-
stituents, as seen in many of the inoculated animals studied
here? That this was much more marked in the absence of
IL-17 signalling implies IL-17 driven defence mechanisms
are important in normal control of such colonization. Para-
doxically, the lack of IL-17 signalling leads to expansion of
Proteobacteria in the nose, which as outlined above would
appear to have a significant energetic advantage over non-
respiring pneumococci. One possibility is that pneumococci
occupy a different anatomical niche from resident Proteo-
bacteria. This then allows the Pneumococcus to proliferate
free from competition from other members of the nasal
microflora, and establish itself as the dominant bacterium
within the nasal space. Whatever the location occupied by
invading pneumococci, it is normally protected by IL-17
driven mechanisms, such as neutrophil influx and/or anti-
microbial peptides, as colonization of pneumococci is much
higher in the Il17ra KO mice.
The sparse correlation analysis of bacterial components
before and after pneumococcal inoculation show some
unexpected findings. Although strong co-operation be-
tween species has been thought to enhance community
stability, both theoretical and experimental analysis have
shown that weak interactions are likely to prevail in stable
communities [39–41]. This is what we have observed in
the resting nasal microbiome of both wild type and Il17ra
KO animals. However, after pneumococcal inoculation we
observed strong positive interactions within members of
the Firmicutes and Proteobacteria groups, but strong an-
tagonism between members of these groups. Promotion
of other Firmicutes by pneumococcal colonization was
unexpected, as bacteriocin production by the pneumococ-
cus is thought to kill closely related Firmicutes and pro-
mote its own growth [22]. We have performed whole
genome RNA sequencing of SRL1 within lung and pleura
and have seen strong expression of the bacteriocin gene
locus (data not shown). The mechanism underlying the
positive co-correlation of Firmicutes with each other
following pneumococcal colonization is thus not clear.
One possibility is the production of carbohydrate energy
sources from the degradation of mucin by pneumococci,
(See figure on previous page.)
Fig 8. Sparse correlation analysis of Firmicutes within nasal microbiome after pneumococcal colonization at day 7 in WT animals (a) and IL-17RA
knockout (KO) animals at day 15 (b). As Fig. 7, but just showing OTUs belonging to the Firmicutes and grouped by family as shown. OTU2, the in-
fecting pneumococcal strain is shown highlighted with a blue dot. Inserted figures are pseudo-p values showing the proportion of 100 resampled
matrices of the original data that had SparCC correlation values more extreme than shown here; p < 0.05 was taken as significant
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which could then cross-feed other Firmicutes [42]. How-
ever, it calls into question the role of bacteriocins in the
ability of pneumococci to colonize the nasopharynx. The
mechanism underlying the positive co-correlations of
members of the proteobacteria are also unclear, as this
group too produces bacteriocins. The negative interac-
tions between the Firmicutes and Proteobacteria we
propose are due to the ability of Proteobacteria to respire
using nitrate as outlined above. In both groups of mice,
the alterations in interactions between the members of the
microbiome were still evident 14 days after pneumococcal
inoculation.
The lung microbiome of wild type animals showed no
disruption following pneumococcal nasal colonization, but
in the absence of IL-17 signalling, there was a significant
alteration in the composition of the microflora. In those
animals that had high levels of pneumococcal nasal
colonization, there was a corresponding increase in the
presence of the colonizing pneumococcus in the lung
microbiome. Despite this, these animals did not show signs
of clinical illness. Even in the absence of IL-17 signalling,
therefore, there is an immune response within the lung that
is sufficient to prevent the development of clinical disease
despite the presence of the pathogenic pneumococcus.
In conclusion, we have shown here that IL-17 signalling
influences the composition of the nasal but not the lung
microbiome. Following pneumococcal colonization, there
were marked changes in nasal microbiome composition,
with wild type animals becoming to resemble the Il17ra
KO animals, with an increase in Proteobacteria. In the
lung, only the Il17ra animals showed altered microbiome
composition, with the invading pneumococcus forming a
considerable proportion of the recovered bacterial popula-
tion in some animals despite absence of clinical disease.
These results demonstrate the important effects of host
cell IL-17 immunity not just on resisting an invading
pathogen but also in altering the resident microbiome.
Such changes may influence the ability of the invading
pneumococcus to establish colonization, and potentially
could be manipulated as a therapeutic intervention.
Conclusions
We show here that the signalling from the IL-17 family cyto-
kines profoundly influences the nasopharyngeal microbiome
Fig. 9. Association between OTU2 (Streptococcus including SRL1) and OTU1 (Ochrobactrum). Normalized abundance data for OTU 2 and OTU1 is
plotted with generalised linear modelled lines of best fit shown for exposed (black) and non-exposed (red) mice. No line of best fit is shown for the
unexposed, lower respiratory tract samples because there was no evidence of a correlation. R2 and p values for each line of best fit are as shown
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of experimental mice. Following colonization with the
pathogen, Streptococcus pneumoniae, there is significantly
enhanced recovery of this microbe from the nasopharynx of
Il17ra knockout mice, and multiple changes in microbiome
composition, even in animal without established pneumo-
coccal colonization. Following pneumococcal inoculation,
there are significant changes in interactions between different
microbial groups, with positive interactions within members
of the Firmicutes and Proteobacteria between themselves,
and strong antagonism between these two groups. These re-
sults demonstrate that IL-17 plays a role not just in altering
innate immune defence directly but also in nasopharyngeal
microbiome composition that impacts upon the ability of
the invading pneumococcus to establish colonization. These
microbial interactions could potentially be manipulated to
reduce pneumococcal colonization and disease.
Methods
Bacterial strains
The clinical strain SRL1 (serotype 3, ST180) was obtained
from the Scottish Haemophilus, Legionella, Meningococ-
cus and Pneumococcus Reference Laboratory.
Animals
All mice were used between 8 and 12 weeks of age. Il17ra
KO mice on a C57Bl/6 background [30] were from T.
Mitchell, University of Glasgow and originally supplied by
Jay Kolls; C57BL/6 mice bred in-house were used as wild-
type controls. For the microbiome studies, wild type and
Il17RAKO animals were cohoused for 6 weeks prior to
the nasal sampling and pneumococcal colonization. Ani-
mal work was carried out under a Project Licence as
Table 1 Frequency of KEGG Orthologs in the imputed metagenome of the murine nasal microbiome calculated using Tax4Fun
KEGG Orthology Classification Abundance of mapped genes, % (IQR) q value
Wild Type IL-17RAKO
Metabolism
Carbohydrate metabolism 13.16 (0.6) 13.59 (0.16) 0.27
Energy Metabolism 7.22 (1.14) 6.35 (0.37) 0.24
Lipid metabolism 3.48 (0.36) 3.45 (0.04) 0.71
Nucleotide metabolism 6.27 (0.38) 6.54 (0.43) 0.27
Amino acid metabolism 11.25 (0.39) 10.78 (0.35) 0.27
Metabolism of other amino acids 2.69 (0.08) 2.73 (0.09) 0.27
Glycan biosynthesis and metabolism 2.85 (0.13) 3.36 (0.26) 0.0016
Metabolism of cofactors and vitamins 8.28 (2.01) 7.63 (0.22) 0.45
Metabolism of terpenoids and polyketides 2.89 (0.15) 2.40 (0.17) 0.0074
Metabolism of other secondary metabolites 0.767 (0.08) 0.651 (0.09) 0.0016
Xenobiotics degradation and metabolism 3.41 (0.78) 2.78 (0.43) 0.039
Genetic information processing
Transcription 0.275 (0.04) 0.273 (0.04) 0.75
Translation 5.95 (0.76) 6.05 (0.97) 0.69
Folding, sorting and degradation 2.75 (0.33) 2.87 (0.27) 0.28
Replication and repair 5.55 (0.65) 5.71 (0.62) 0.56
Environmental information processing
Membrane transport 11.09 (1.59) 12.51 (0.5) 0.13
Signal transduction 5.60 (1.17) 5.61 (1.09) 0.77
Signaling molecules and interaction 0.000276 (0) 0.000106 (0) 0.025
Cellular processes
Transport and catabolism 0.266 (0.07) 0.259 (0.02) 0.68
Cell motility 1.27 (0.6) 1.03 (0.62) 0.28
Cell growth and death 1.52 (0.08) 1.39 (0.04) 0.0016
Human disease
Infectious Diseases: Bacterial 1.84 (0.14) 2.42 (0.29) 0.0019
Differences were analysed using Mann-Whitney tests corrected for multiple comparisons using the method of Benjamini, Krieger and Yekutieli with a false
discovery rate of 1%. Significant differences between Wild type and IL-17RAKO animals are shown in bold ( q value < 0.01)
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required by UK Home Office regulations as well as scru-
tiny and approval by an Institutional Review board.
Ethics
All animal work was carried out with the authorization of the
UK Government Home Office, as approved by the awarding
of a Project Licence Number 60/4361 and was additionally
approved by the University of Glasgow Animal Use Ethics
Review Board, with the same reference number. This legisla-
tion ensures that all animal work carried out is in accordance
with the UK Law as set out in the Animals (Scientific Proce-
dures) Act 1986 (ASPA). This Act adopts the International
European Union regulations set out in European Directive
2010/63/EU on the protection of animals used for scientific
purposes, to which all our animal work adhered.
Bacterial Colonisation
Bacterial colonisation was carried out by gently restrain-
ing mice and placing 10μl of PBS containing 5 x 105 cfu
of SRL1 on the external nares so that it was aspirated
into the nasal tract. Animals were not sedated during
this procedure to minimise aspiration into the lower re-
spiratory tract. Animals were monitored closely during
experiments with monitoring of bodyweight and assess-
ment for signs of illness.
Bacterial Infection and quantification of IL-17 targets
To analyse the gene responses in wild type and IL-17RA
knockout animals, we increased the dose of added bacteria
by inoculating 10 μl of PBS containing 106 SRL1. 12 hours
following inoculation, lungs were placed in RNA later solu-
tion (Life Technologies) and frozen at -80°C until use. After
gentle thawing, lungs were transferred into a 2ml centrifuge
tube with a 5mm steel bearing (Qiagen) and 1ml Trizol
(Life Technologies). Samples were loaded into a TissueLyser
LT (Qiagen) and pulsed at 50 Hz for 5 minutes. RNA was
then extracted from the lung homogenate using a PureLink
RNA Mini Kit (Life Technologies) and first strand cDNA
generated using SuperScript First-Strand Synthesis System
(Life Technologies) using oligoDT primers according to the
manufacturer’s instructions.
PCR was then conducted using Fast SYBR Master Mix
(Life Technologies) according to the manufacturer’s in-
structions using the following primers: TBP forward
CCCCACAACTCTTCCATTCT, reverse GCAGGAGT-
GATAGGGGTCAT; β-defensin 4 forward TCTCTTCA-
CATTTCTCCTGGTG, reverse TGGATTGTTGATAA
TTTGGGTAAA; S100A8 forward TGCGATGGTGATA
AAAGTGG, reverse GGCCAGAAGCTCTGCTACTC;
MIP-1α forward CGTTCCTCAACCCCCATC, reverse T
GTCAGTTCATGACTTTGTCATCAT. Gene expression
was compared to that of the housekeeping gene TATA-
binding protein (TBP) and expressed as relative gene ex-
pression according to the ΔΔCT method.
Respiratory tract sampling and culture
Mice were culled by inhalation of CO2. The external nares
were carefully cleaned and allowed to dry. The trachea
was exposed and incised to allow the placement of a fine
bore pastette. To wash the nasal passages, the pastette tip
was advanced via the trachea into the posterior nasophar-
ynx until resistance was felt and 1 ml of phosphate buff-
ered saline (PBS) expressed through the nose. Broncho-
alveolar lavage was performed with 1ml of PBS. Pneumo-
cocci were enumerated by serial dilution onto 5% horse
blood agar and incubated overnight in 5% CO2. For esti-
mation of nasal neutrophil content, the nasal washes were
washed three by centrifugation at 400g for 5 minutes in
PBS before resuspending in FACS buffer (BD Biosciences).
Cells were stained with anti-Gr-1 antibody (clone
RB6-8C5, Biolegend) conjugated to PE diluted 1:1000
with FACS buffer for 30 minutes at 37°C and then
analysed using a CyAN ADP Flow cytometer (Becton
Dickinson).
16S DNA amplification and sequencing
Genomic DNA was extracted from nasal washes and BALF
using a Qiagen DNeasy Blood and Tissue Mini Kit accord-
ing to the manufacturer’s instructions using the suggested
modification to enhance lysis of gram-positive organisms
and eluted into 100 μl. After extraction, the V1-V2 region
of the 16S RNA was amplified using NEB Next High
Fidelity 2x PCR Master Mix (New England Biolabs)
using 10 μl of genomic DNA and 12.5 pmol of the
high performance liquid chromatography barcoded
primers shown in Additional file 2: Table S1 (Eurofins
Genomics). Thus, PCR products from the different
animals and time points could be identified after se-
quencing by their associated barcode, allowing pool-
ing of samples for sequencing. PCR was conducted
using an initial denaturation period of 30 seconds at
98 C followed by 25 cycles consisting of denaturation
for 10 seconds at 98 C, annealing for 30 seconds at
58 C, and extension for 30 seconds at 72 C before a
final extension for 1 minute at 72 C.
Presence of a single PCR product at the expected band
size of 440 bp was confirmed by 1.8% agarose gel elec-
trophoresis before purification of the PCR product using
a Qiagen PCR purification kit according to the manufac-
turer’s instructions. Samples from different animals and
time points were then pooled.
Sequencing was performed by the Centre for Genomic
Research (CGR), University of Liverpool. Paired end
(2x250bp) sequencing of pooled amplicon sample on the
Illumina MiSeq platform was conducted using higher
levels of Phix to increase diversity. Sequences were
demultiplexed by the CGR.
Sequences were processed using a processing pipeline.
Briefly, sequences were trimmed using Sickle [43] and
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forward and reverse reads were overlapped using PAN-
DASEQ [44] with a minimum overlap of 50bp to assem-
ble the forward and reverse reads into a single sequence
spanning the entire V1-V2 region [45]. Sequences were
then dereplicated and chimeric sequences removed using
UCHIME [46]. Operational taxonomic units (OTUs)
were then generated using UPARSE [47] and taxo-
nomic assignments were generated using the standa-
lone RDPclassifier v2.6 [48, 49] with the default
–minWords option of 5. Tax4Fun [50] was used to
predict the functional capabilities of microbial com-
munities based on 16S rRNA datasets after blasting
the OTUs against the Silva database.
Detection of pneumococci using PCR amplification of cpsA
DNA was extracted from pneumococci using a DNeasy
Blood and Tissue Kit (Qiagen) according to the
manufacturer’s instructions using the protocol for gram
positive bacteria. PCR was carried out using Qiagen
Multiplex PCR mastermix according to the manufac-
turer’s instructions. Primers for the cpsA gene were:
GCAGTACAGCAGTTTGTTGGACTGACC (forward)
and GAATATTTTCATTATCAGTCCCAGTC (reverse).
After an initial incubation at 95°C for 15 minutes to
activate the DNA polymerase, 35 cycles were performed
consisting of denaturation at 95°C for 30 seconds, an-
nealing at 54°C for 90 seconds and extension at 72°C for
60 seconds. A terminal extension step of 10 minutes was
included. Final mixtures were run on a 2% agarose gel at
100V for 2 hours. The amplification with these primers
generates a 160 bp band.
Statistics
Statistical analysis was conducted using R [51]. Nonmet-
ric Distance Scaling (NMDS) plots of community data
(OTUs at 3% divergence) using Bray-Curtis dissimilarity
between samples were produced with the metamds func-
tion in the Vegan package. Samples were grouped for
different conditions and the mean ordination value and
spread of points shown using Vegan’s ordiellipse func-
tion. Differences between groups were evaluated using
PERMANOVA in the adonis function in the Vegan
package [25]. Sparse correlation analysis was performed
using Spar-CC [52] as implemented in R [53]. Signifi-
cance testing of correlation co-efficients was calculated
by re-sampling (with replacement) the normalised count
data to produce 100 resampled count matrices for which
new Spar-CC correlations were calculated. Pseudo p
values were than calculated as the proportion of these
resampled Spar-CC correlation co-efficients that were
more extreme than the original value; p < 0.05 was taken
as significant.
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